Precision Biosciences Share Price (NASDAQ: DTIL)

$4.73

▲

-0.04

(-0.84%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Precision Biosciences Stock chart to analyse performance

Precision Biosciences stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$4.23
Today's High:$4.85
$4.73
10.57%
Downside
Day's Volatility :12.78%
Upside
2.47%
52 Weeks Low:$3.61
52 Weeks High:$11.09
$4.73
23.68%
Downside
52 Weeks Volatility :67.45%
Upside
57.35%

Precision Biosciences Stock Returns

Period	Precision Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.56%	2.3%	0.0%
6 Months	-11.26%	-5.9%	0.0%
1 Year	-48.24%	-10.9%	0.0%
3 Years	-92.19%	1.7%	-12.4%

Precision Biosciences Inc Key Stats

Check Precision Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.77
Open	$4.8
Today's High	$4.85
Today's Low	$4.23
Market Capitalization	$56.2M
Today's Volume	$106.4K
52 Week High	$11.09
52 Week Low	$3.61
Revenue TTM	$1.3M
EBITDA	$-88.2M
Earnings Per Share (EPS)	$-10.15
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-143.89%

Stock Returns calculator for Precision Biosciences Stock including INR - Dollar returns

The Precision Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Precision Biosciences investment value today

Current value as on today

₹57,777

Returns

₹42,223

(-42.22%)

Returns from Precision Biosciences Stock

₹46,433 (-46.43%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Precision Biosciences Stock

75%

Period: Jul 16, 2025 to Aug 15, 2025. Change in 30 Days versus previous period

Search interest for Precision Biosciences Stock from India on INDmoney has increased by 75% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Precision Biosciences Inc

Name
Holdings %
Name
Holdings %
Aquilo Capital Management, LLC
6.55%
TANG CAPITAL MANAGEMENT LLC
6.07%
Vanguard Group Inc
2.54%
Acadian Asset Management LLC
2.24%
BOOTHBAY FUND MANAGEMENT, LLC
1.80%
Balyasny Asset Management LLC
1.71%

Analyst Recommendation on Precision Biosciences Stock

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Precision Biosciences(by analysts ranked 0 to 5 stars)

Precision Biosciences Share Price Target

What analysts predicted

Upside of 544.82%

Target:

$30.50

Current:

$4.73

Precision Biosciences share price target is $30.50, a slight Upside of 544.82% compared to current price of $4.73 as per analysts' prediction.

Precision Biosciences Stock Insights

Price Movement
In the last 3 years, DTIL stock has moved down by -4.0%
Price Movement
In the last 3 years, DTIL stock has moved down by -92.3%
Decreasing Revenue
Revenue is down for the last 3 quarters, 638.0K → 18.0K (in $), with an average decrease of 66.7% per quarter
Increasing Revenue
Revenue is up for the last 2 quarters, 83.48 Cr → 116.51 Cr (in ₹), with an average increase of 28.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -42.12 Cr → 14.35 Cr (in ₹), with an average increase of 393.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, 32.74M → -23.52M (in $), with an average decrease of 47.1% per quarter
DTIL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 115.6%
DTIL vs ALNY (1 yr)
In the last 1 year, Kaveri Seed Company Ltd has given 6.5% return, outperforming this stock by 25.1%
DTIL vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 96.8% return, outperforming this stock by 189.1%
DTIL vs ALNY (3 yr)
In the last 3 years, Kaveri Seed Company Ltd has given 134.5% return, outperforming this stock by 138.5%
Price to Sales
ForDTIL every $1 of sales, investors are willing to pay $32.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Precision Biosciences Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$22.2M	↑ 104.34%
Net Income	$-83.3M	↑ 80.94%
Net Profit Margin	-374.59%	↑ 48.43%

	FY20	Y/Y Change
Revenue	$24.3M	↑ 9.2%
Net Income	$-109.0M	↑ 30.86%
Net Profit Margin	-448.86%	↓ 74.27%

	FY21	Y/Y Change
Revenue	$115.5M	↑ 375.72%
Net Income	$-30.9M	↓ 71.64%
Net Profit Margin	-26.76%	↑ 422.1%

	FY22	Y/Y Change
Revenue	$25.1M	↓ 78.28%
Net Income	$-122.9M	↑ 297.53%
Net Profit Margin	-489.71%	↓ 462.95%

	FY23	Y/Y Change
Revenue	$48.7M	↑ 94.15%
Net Income	$-61.3M	↓ 50.11%
Net Profit Margin	-125.84%	↑ 363.87%

	FY24	Y/Y Change
Revenue	$68.7M	↑ 40.98%
Net Income	$7.2M	↓ 111.69%
Net Profit Margin	10.43%	↑ 136.27%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$17.6M	↑ 149.84%
Net Income	$8.6M	↓ 152.72%
Net Profit Margin	48.84%	↑ 280.28%

	Q2 FY24	Q/Q Change
Revenue	$49.9M	↑ 183.77%
Net Income	$32.7M	↑ 281.33%
Net Profit Margin	65.63%	↑ 16.79%

	Q3 FY24	Q/Q Change
Revenue	$576.0K	↓ 98.85%
Net Income	$-16.4M	↓ 150.15%
Net Profit Margin	-2.9K%	↓ 2917.19%

	Q4 FY24	Q/Q Change
Revenue	$638.0K	↑ 10.76%
Net Income	$-17.7M	↑ 8.04%
Net Profit Margin	-2.8K%	↑ 70.21%

	Q1 FY25	Q/Q Change
Revenue	$29.0K	↓ 95.45%
Net Income	$-20.6M	↑ 15.89%
Net Profit Margin	-70.9K%	↓ 68132.44%

	Q2 FY25	Q/Q Change
Revenue	$18.0K	↓ 37.93%
Net Income	$-23.5M	↑ 14.37%
Net Profit Margin	-130.7K%	↓ 59752.88%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$22.2M	↑ 104.34%

	FY20	Y/Y Change
Profit	$24.3M	↑ 9.2%

	FY21	Y/Y Change
Profit	$115.5M	↑ 375.72%

	FY22	Y/Y Change
Profit	$16.1M	↓ 86.07%

	FY23	Y/Y Change
Profit	$40.5M	↑ 151.47%

	FY24	Y/Y Change
Profit	$68.7M	↑ 69.74%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$17.6M	↑ 220.76%

	Q2 FY24	Q/Q Change
Profit	$49.9M	↑ 183.77%

	Q3 FY24	Q/Q Change
Profit	$576.0K	↓ 98.85%

	Q4 FY24	Q/Q Change
Profit	$638.0K	↑ 10.76%

	Q1 FY25	Q/Q Change
Profit	$29.0K	↓ 95.45%

	Q2 FY25	Q/Q Change
Profit	$-678.0K	↓ 2437.93%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-71.0M	↑ 37.3%
Investing Cash Flow	$-24.7M	↑ 57.48%
Financing Cash Flow	$173.4M	↑ 60.86%

	FY20	Y/Y Change
Operating Cash Flow	$-87.4M	↑ 23.05%
Investing Cash Flow	$-5.0M	↓ 79.6%
Financing Cash Flow	$1.3M	↓ 99.23%

	FY21	Y/Y Change
Operating Cash Flow	$-10.9M	↓ 87.58%
Investing Cash Flow	$-5.8M	↑ 15.34%
Financing Cash Flow	$70.5M	↑ 5206.32%

	FY22	Y/Y Change
Operating Cash Flow	$-45.8M	↑ 321.57%
Investing Cash Flow	$-3.3M	↓ 42.81%
Financing Cash Flow	$95.0M	↑ 34.69%

	FY23	Y/Y Change
Operating Cash Flow	$-84.1M	↑ 83.84%
Investing Cash Flow	$5.8M	↓ 275.63%
Financing Cash Flow	$5.4M	↓ 94.33%

	FY24	Y/Y Change
Operating Cash Flow	$-58.4M	↓ 30.52%
Investing Cash Flow	$-215.0K	↓ 103.69%
Financing Cash Flow	$50.5M	↑ 836.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-19.0M	↑ 125.35%
Investing Cash Flow	$-26.0K	↓ 161.9%
Financing Cash Flow	$40.1M	↑ 1317.79%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-14.9M	↓ 21.66%
Investing Cash Flow	$-28.0K	↑ 7.69%
Financing Cash Flow	$702.0K	↓ 98.25%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-5.9M	↓ 60.24%
Investing Cash Flow	$-64.0K	↑ 128.57%
Financing Cash Flow	$3.7M	↑ 431.77%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-18.7M	↑ 216.02%
Investing Cash Flow	$-97.0K	↑ 51.56%
Financing Cash Flow	$5.9M	↑ 58.59%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-19.1M	↑ 1.98%
Investing Cash Flow	$-314.0K	↑ 223.71%
Financing Cash Flow	$10.7M	↑ 80.52%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-20.3M	↑ 6.4%
Investing Cash Flow	$-12.0K	↓ 96.18%
Financing Cash Flow	$5.3M	↓ 50.41%

Precision Biosciences Technicals Summary

Sell

Neutral

Buy

Precision Biosciences is currently in a neutral trading position according to technical analysis indicators.

Precision Biosciences Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Precision Biosciences Inc	-1.51%	-11.26%	-48.24%	-92.19%	-97.56%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Precision Biosciences Inc	4.38	NA	NA	-8.17	-1.44	-0.41	NA	2.93

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Precision Biosciences Inc	Buy	$56.2M	-97.56%	4.38	0.0%

About Precision Biosciences Inc

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Organization	Precision Biosciences
Employees	102
CEO	Mr. Naresh Tanna
Industry	Biotechnology

Key Management of Precision Biosciences Inc

Name	Title
Mr. Michael Amoroso	President, CEO & Director
Dr. Jefferson J. Smith Ph.D.	Co-Founder & Chief Research Officer
Mr. John Alexander Kelly R.Ph.	CFO & Principal Accounting Officer
Dr. Cassie Gorsuch Ph.D.	Chief Scientific Officer
Mr. Naresh Tanna	Chief of Staff to CEO & Head of Investor Relations
Mr. Dario Scimeca J.D.	General Counsel & Secretary
Ms. Juli Blanche	Chief People Officer
Ms. Cindy Atwell	Chief Development & Business Officer
Mr. Neil Leatherbury M.S.	Senior VP and Head of Chemistry, Manufacturing & Controls

Important FAQs about investing in DTIL Stock from India :

What is Precision Biosciences share price today?

Precision Biosciences share price today is $4.73 as on August 16, 2025 at 1:29 AM IST at the close of the market. Precision Biosciences share today touched a day high of $4.85 and a low of $4.23.

What is the 52 week high and 52 week low for Precision Biosciences share?

Precision Biosciences share touched a 52 week high of $11.09 and a 52 week low of $3.61. Precision Biosciences stock price today, August 16, 2025 at 1:29 AM IST is trending at $4.73, lower by 57.35% versus the 52 week high.

How to invest in Precision Biosciences Stock (DTIL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Precision Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precision Biosciences Shares that will get you 0.3171 shares as per Precision Biosciences share price of $4.73 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Precision Biosciences Stock (DTIL) from India?

Indian investors can start investing in Precision Biosciences (DTIL) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Precision Biosciences stock (as per the Rupee-Dollar exchange rate as on August 16, 2025). Based on Precision Biosciences share’s latest price of $4.73 as on August 16, 2025 at 1:29 AM IST, you will get 2.1142 shares of Precision Biosciences. Learn more about fractional shares .

What are the returns that Precision Biosciences has given to Indian investors in the last 5 years?

Precision Biosciences stock has given -97.56% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?